Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 24, 2025

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
07:31

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

18.0K

Sarcoma incidence and subtype distribution in Israel - A population-based study.

Oded Icht1, Ron Lewin1, Lilach Yosef1

  • 1Davidoff Cancer Institute, Rabin Medical Center, Petah Tikva, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Israel.

Cancer Epidemiology
|December 22, 2020
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same author

LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli Health Maintenance Organization (HMO).

Expert review of anticancer therapy·2026
Same author

Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study.

JTO clinical and research reports·2026
Same author

Sotorasib in Advanced <i>KRAS</i> G12C-Mutated NSCLC: Results From the Global Expanded Access Program, Including Patients With Poor Performance Status and a History of CNS Metastases.

JTO clinical and research reports·2026
Same author

High-Dose Twice-Daily Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Real-World Retrospective Experience from Two Tertiary Centers.

OncoTargets and therapy·2026
Same author

Classic Kaposi Sarcoma: Current Treatment Strategies and Emerging Therapeutic Approaches.

Cancers·2026

Sarcoma incidence in Israel has declined between 1996-2017. Kaposi sarcoma (KS), liposarcoma, and leiomyosarcoma were the most common subtypes, with KS showing the highest incidence.

Area of Science:

  • Oncology
  • Epidemiology
  • Cancer Research

Background:

  • Sarcomas are rare cancers with diverse subtypes.
  • Understanding national incidence and subtype distribution is crucial for public health planning.
  • Accurate cancer registration is vital for reliable epidemiological data.

Purpose of the Study:

  • To describe sarcoma incidence and subtype distribution in Israel from 1996-2017.
  • To evaluate the accuracy of sarcoma case registration in the national registry.
  • To provide the first comprehensive report on sarcoma epidemiology in Israel.

Main Methods:

  • Analysis of sarcoma incidence data from 1996-2017.
  • Evaluation of concordance between pathology reports and the national registry (INCR).
Keywords:
IsraelKaposi sarcomaSarcomaSarcoma incidence

More Related Videos

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.1K
Three-Dimensional Reconstruction of Orbital Fractures
08:18

Three-Dimensional Reconstruction of Orbital Fractures

Published on: May 16, 2025

466

Related Experiment Videos

Last Updated: Nov 24, 2025

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
07:31

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

18.0K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.1K
Three-Dimensional Reconstruction of Orbital Fractures
08:18

Three-Dimensional Reconstruction of Orbital Fractures

Published on: May 16, 2025

466
  • Assessment of sarcoma subtype distribution, including Kaposi sarcoma (KS), liposarcoma, and leiomyosarcoma.

    • Main Results:

    • Overall sarcoma incidence showed an annual decline of -2.1% in men and -1.5% in women.
    • Registration concordance between pathology reports and the INCR was 90%.
    • Kaposi sarcoma (KS) was the most common subtype (21%), followed by liposarcoma (14.4%) and leiomyosarcoma (10.8%). KS incidence was 1.6/100,000 persons.

    Conclusions:

    • This study provides the first detailed description of sarcoma incidence and subtype epidemiology in Israel.
    • Sarcoma incidence has decreased in Israel over the past two decades.
    • High concordance rates suggest reliable sarcoma data registration in Israel.